225 related articles for article (PubMed ID: 28872704)
1. Design, Synthesis, and Biological Evaluation of New Peptide Analogues as Selective COX-2 Inhibitors.
Ahmaditaba MA; Shahosseini S; Daraei B; Zarghi A; Houshdar Tehrani MH
Arch Pharm (Weinheim); 2017 Oct; 350(10):. PubMed ID: 28872704
[TBL] [Abstract][Full Text] [Related]
2. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of new pyrazino[1,2-a]benzimidazole derivatives as selective cyclooxygenase (COX-2) inhibitors.
Azami Movahed M; Daraei B; Shahosseini S; Esfahanizadeh M; Zarghi A
Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800265. PubMed ID: 30561073
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
Ghodsi R; Zarghi A; Daraei B; Hedayati M
Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Kakhgi S; Hadipoor A; Daraee B; Dadrass OG; Hedayati M
Bioorg Med Chem Lett; 2008 Feb; 18(4):1336-9. PubMed ID: 18226898
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.
Li Z; Wang ZC; Li X; Abbas M; Wu SY; Ren SZ; Liu QX; Liu Y; Chen PW; Duan YT; Lv PC; Zhu HL
Eur J Med Chem; 2019 May; 169():168-184. PubMed ID: 30877972
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors.
Ahmaditaba MA; Houshdar Tehrani MH; Zarghi A; Shahosseini S; Daraei B
Iran J Pharm Res; 2018; 17(1):87-92. PubMed ID: 29755541
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of new (E)- and (Z)-1,2,3-triaryl-2-propen-1-ones as selective COX-2 inhibitors.
Arfaie S; Zarghi A
Eur J Med Chem; 2010 Sep; 45(9):4013-7. PubMed ID: 20691338
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents.
Yao RS; Lu XQ; Guan QX; Zheng L; Lu X; Ruan BF
Eur J Med Chem; 2013 Apr; 62():222-31. PubMed ID: 23353741
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity.
Vahedpour T; Kaur J; Hemmati S; Hamzeh-Mivehroud M; Alizadeh AA; Wuest F; Dastmalchi S
Chem Biodivers; 2021 Mar; 18(3):e2000832. PubMed ID: 33620122
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of new 1,4-diarylazetidin-2-one derivatives (β-lactams) as selective cyclooxygenase-2 inhibitors.
Arefi H; Naderi N; Shemirani ABI; Kiani Falavarjani M; Azami Movahed M; Zarghi A
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900293. PubMed ID: 31917485
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of pyrazole-pyrazoline hybrids as cancer-associated selective COX-2 inhibitors.
Akhtar W; Marella A; Alam MM; Khan MF; Akhtar M; Anwer T; Khan F; Naematullah M; Azam F; Rizvi MA; Shaquiquzzaman M
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000116. PubMed ID: 33015829
[TBL] [Abstract][Full Text] [Related]
16. Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities.
Abdelazeem AH; El-Saadi MT; Said EG; Youssif BGM; Omar HA; El-Moghazy SM
Bioorg Chem; 2017 Dec; 75():127-138. PubMed ID: 28938224
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of new rofecoxib analogs as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of the methanesulfonyl pharmacophore by a N-acetylsulfonamido bioisostere.
Zarghi A; Rao PN; Knaus EE
J Pharm Pharm Sci; 2007; 10(2):159-67. PubMed ID: 17706175
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of new 1,3-benzdiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Zebardast T; Hajighasemali F; Alipoor E; Daraie B; Hedayati M
Arch Pharm (Weinheim); 2012 Apr; 345(4):257-64. PubMed ID: 22076641
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zebardast T; Zarghi A; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem Lett; 2009 Jun; 19(12):3162-5. PubMed ID: 19447036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]